Evaxion Biotech (EVAX) to implement ADS ratio change

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Evaxion Biotech (EVAX) to implement ADS ratio change

Evaxion announces plan to implement ADS ratio change

December 30, 2024 8:00 AM EST

COPENHAGEN, Denmark, December 30, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (Evaxion), a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, today announced that it plans to change the ratio of its American Depositary Shares (ADSs) to its ordinary shares, DKK 1 nominal value (the ADS ratio), from the current one (1) ADS representing ten (10) ordinary share to a new ADS ratio of one (1) ADS representing fifty (50) ordinary shares (the ADS ratio change). The ADS ratio change is expected to become effective on or about January 13, 2025, U.S. Eastern Time (the effective date).

... More